Sign In to View Organizational & Contract Pricing
Select a Size
About This Item
Empirical Formula (Hill Notation):
C7H7NO4
CAS Number:
Molecular Weight:
169.13
Beilstein:
1528952
MDL number:
UNSPSC Code:
12352100
PubChem Substance ID:
Assay
≥98.0% (HPLC)
mp
103-106 °C (lit.)
108-111 °C
SMILES string
OC(=O)CCN1C(=O)C=CC1=O
InChI
1S/C7H7NO4/c9-5-1-2-6(10)8(5)4-3-7(11)12/h1-2H,3-4H2,(H,11,12)
InChI key
IUTPJBLLJJNPAJ-UHFFFAOYSA-N
Looking for similar products? Visit Product Comparison Guide
Other Notes
Reagent for the modification of peptides, proteins with an SH-label, probe for membrane SH-groups, Used for the preparation of peptide-protein conjugates
Signal Word
Warning
Hazard Statements
Precautionary Statements
Hazard Classifications
Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
Storage Class Code
13 - Non Combustible Solids
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
D.G. Griffiths et al.
Biochemical Society Transactions, 11, 753-753 (1983)
L Moroder et al.
Biological chemistry Hoppe-Seyler, 368(7), 855-861 (1987-07-01)
In previous studies on model compounds we have found that the maleimide function is sufficiently stable under the conditions of peptide synthesis to allow its incorporation at preselected positions of a peptide chain in earlier steps of the synthetic route.
Wuensch, E.
Hoppe-Seyler'S Zeitschrift fur Physiologische Chemie, 366, 53-53 (1985)
Sandra Loera-Serna et al.
Chemistry (Weinheim an der Bergstrasse, Germany), 25(17), 4398-4411 (2019-01-05)
The metal-organic framework (MOF) HKUST-1 was employed as an interaction matrix for fundamental loading studies of anthraquinone dyes. Chosen dyes were alizarin (A), alizarin S (AS), disperse blue 1 (B1), disperse blue 3 (B3), disperse blue 56 (B56) and purpurin
Zhipeng Chen et al.
Journal of controlled release : official journal of the Controlled Release Society, 191, 123-130 (2014-06-04)
Covalent modification of a drug with a peptide moiety has been extensively used as an effective strategy to improve the drug's therapeutic outcome. One important consideration in the design of such a prodrug is the release of the free drug
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service